Clinical reference Biomarker Directory
Back to directory

Follicle stimulating hormone

Established

FSH is a pituitary hormone used selectively to evaluate menopause timing and fertility, per narrowed current guidelines.

Also known as FSH follitropin
In plain language

FSH helps regulate egg and sperm development. Current guidelines say most women over 45 with typical menopause symptoms don't need this blood test at all — it's mainly reserved for younger women with early menopause symptoms or atypical presentations.

Biomarker & context

Follicle stimulating hormone (FSH) is a pituitary hormone regulating ovarian follicle development in women and sperm production in men, historically used to help diagnose menopause and evaluate fertility.

What it indicates

Elevated FSH in a woman with menstrual changes and symptoms supports a menopause or premature ovarian insufficiency diagnosis; in men, elevated FSH with low sperm count suggests a testicular (rather than pituitary) cause of infertility.

Diagnosis & clinical testing

Current guidance (NICE 2024, updated through 2026) is more restrictive than older practice: FSH testing isn't recommended to diagnose menopause in women over 45 with typical symptoms, since clinical symptoms alone are sufficient. Testing is reserved for women under 40 with suspected premature ovarian insufficiency (needing two elevated readings 4-6 weeks apart) or women 40-45 with atypical presentations.

Guiding treatment

FSH testing is invalid in women on combined hormonal contraception, since the medication suppresses FSH regardless of true menopausal status; this should be clearly flagged whenever FSH results are being interpreted in that context.

Clinical significance

Current guidance limits routine testing to younger women or atypical presentations rather than typical menopause.

References
  1. NICE. (2024, updated 2026). Menopause: Identification and Management Guideline.
  2. Endocrinology Today. (2025). Premature ovarian insufficiency: recommendations from the new guidelines.